H35.143 Retinopathy of prematurity, stage 3, bilateral

Name of the Condition

• Retinopathy of prematurity, stage 3, bilateral

Summary

Retinopathy of prematurity (ROP) is a disorder affecting premature infants, characterized by abnormal blood vessel development in the retina. Stage 3 represents a more advanced phase where abnormal blood vessels grow and partially detach the retina. This stage carries a higher risk of progression to severe vision loss if untreated, requiring prompt evaluation and intervention. Bilateral involvement indicates both eyes are affected.

Causes

ROP is caused by the incomplete growth of retinal blood vessels in premature infants. The retina, which normally develops blood vessels by full-term birth, may not have fully vascularized in preterm infants. Factors such as oxygen therapy, fluctuations in oxygen levels, and the infant's overall immaturity contribute to abnormal vessel growth, with stage 3 reflecting significant retinal changes.

Risk Factors

• Prematurity (especially infants born before 31 weeks of gestation).
• Low birth weight (typically under 1500 grams).
• Oxygen therapy or fluctuations in oxygen levels during neonatal care.
• Multiple births (e.g., twins or triplets).
• Certain medical conditions affecting oxygen delivery or retinal development.

Symptoms

In stage 3, ROP may not present obvious symptoms in infants. Severe cases can lead to abnormal eye movements, a white appearance of the pupil (leukocoria), or vision impairment as the condition progresses.

Diagnosis

Diagnosis involves a comprehensive eye examination by a pediatric ophthalmologist, typically using indirect ophthalmoscopy to assess retinal changes. Staging follows standardized criteria, with stage 3 defined by the extent of retinal detachment and abnormal vessel growth. Bilateral involvement is confirmed by evaluating both eyes.

Treatment Options

Treatment depends on severity and may include laser therapy, cryotherapy, or anti-VEGF injections to halt abnormal vessel growth. Close monitoring is essential, with intervention recommended for progressive or high-risk cases to prevent vision loss.

Prognosis and Follow-Up

Prognosis varies based on disease severity and response to treatment. Early intervention improves outcomes, but some infants may develop long-term vision issues. Follow-up care includes regular eye examinations to monitor for recurrence or complications like retinal detachment.

Complications

Potential complications include retinal detachment, myopia, strabismus, amblyopia, and blindness. Bilateral involvement increases the risk of significant visual impairment if left untreated.

Lifestyle & Prevention

Prevention focuses on optimizing neonatal care, including careful oxygen management and monitoring of premature infants. Early detection through routine screening reduces progression risk.

When to Seek Professional Help

Seek immediate evaluation if abnormal eye movements, leukocoria, or vision concerns are observed. Prompt referral to a pediatric ophthalmologist is critical for timely diagnosis and treatment.

Tips for Medical Coders

Document the bilateral nature of the condition clearly in the medical record. Ensure stage 3 is confirmed via clinical examination and note any interventions performed. Code H35.143 is specific to bilateral stage 3 ROP; verify documentation aligns with the diagnosis.